Article History
First Online: 14 September 2020
Competing interests
: G.R.S. is a cofounder and shareholder of Espervita Therapeutics. McMaster University has received funding from Espervita Therapeutics, Esperion Therapeutics and Poxel Pharma for research conducted by the laboratory of G.R.S. G.R.S. has received consulting or speaking fees from Allysta Pharmaceuticals, Eli Lilly, Esperion Therapeutics, Merck, Poxel Pharma and Takeda. I.N. and D.M.A. have no conflicts of interest to report.